A CMV blood test is one of the harder results to read on your own. It usually comes back as two lines, IgG and IgM, sometimes with a third called avidity, and the combination matters far more than any single value. The topic is in the news because France has just gone further than most countries: on August 4, 2026, its national health authority published a full protocol telling clinicians exactly what to do after first-trimester cytomegalovirus screening. The United States has not taken that step. In this article you’ll learn what each result pattern means, how US practice differs, and what happens when a recent infection is confirmed.
Why CMV testing is being discussed again
Cytomegalovirus is extremely common and usually harmless. Roughly half of adults have already been infected, most without ever noticing. The concern is narrow and specific: a first infection in the two months before conception or during the first trimester can reach the fetus and cause hearing loss or neurological effects. Congenital CMV affects a small share of births but ranks as the leading infectious cause of congenital disability.
France now recommends offering serology to every pregnant woman who is not immune or whose status is unknown, repeating it every four weeks until 14 weeks, and stopping screening after that point because the risk of harm beyond the first trimester is close to zero. US guidance remains selective. The Mayo Clinic notes that routine CMV screening is not standard in American pregnancy care; testing is ordered when there has been a known exposure, when symptoms such as fever and swollen glands appear, when an ultrasound shows findings that suggest infection, or when the mother is immunocompromised.
How to read a CMV blood test
Two antibody classes do the work. IgM antibodies appear early and point toward a possibly recent infection. IgG antibodies appear later and persist for life, marking past contact with the virus. Our library also explains the wider serology test panel and its uses.
| Pola hasil | Apa yang disarankan | Langkah selanjutnya yang umum |
|---|---|---|
| IgG negative, IgM negative | No previous infection, so no immunity | Prevention counseling; repeat testing if exposure is likely |
| IgG positive, IgM negative | Past infection, no sign of a recent one | Usually no further testing |
| IgG positive, IgM positive, low avidity | Consistent with a recent first infection | Referral to maternal-fetal medicine; amniotic fluid PCR considered |
| IgG positive, IgM positive, high avidity | Older infection; IgM can linger or rebound | Reassurance, with clinical context reviewed |
| IgG turns positive between two samples | Seroconversion, meaning infection between the draws | Specialist referral and dating of the infection |
Why a positive IgM alone proves nothing
This is the single most misread part of the report. The CDC states plainly that IgM alone is not adequate to diagnose a first infection, because it can stay detectable for months, reappear during reactivation, or turn positive during an unrelated viral illness. The false-positive rate is high enough that no decision should rest on that line by itself.
Avidity testing solves part of the problem. It measures how tightly IgG antibodies bind the virus. After a first infection, binding starts weak and matures to strong over roughly two to four months, so low avidity points to a recent event and high avidity points to an older one. One caveat matters in the United States: commercial avidity assays are not FDA-approved, so laboratories and clinicians interpret them with caution. Readers comparing patterns across infections can also review Toxoplasmosis IgG and IgM results, which follow the same antibody logic.
A CMV infection can also raise white cell counts, which is why some people first notice something unusual after reviewing high lymphocyte counts and their causes. That finding is nonspecific and never diagnostic on its own. Our library also details the IgG immunoglobulin G blood test.
What happens when a recent infection is confirmed
Serology dates the mother’s infection. It does not tell you whether the virus reached the fetus. That question is answered by PCR on amniotic fluid, generally offered from around 18 weeks and no earlier than about 21 days after the presumed maternal infection. A negative result is reassuring; a positive result moves care to a specialist team with serial ultrasound and, in many protocols, fetal MRI later in pregnancy.
Antiviral treatment has changed the conversation. High-dose oral valacyclovir started early after a first-trimester infection lowers the chance of transmission to the fetus. France has now built this into its national pathway through a compassionate-use framework. In the US it is used off-label in specialized centers rather than as routine care, so availability depends on where you are treated.
For newborns, the rules are different again. Antibody tests cannot diagnose congenital CMV in a baby, because maternal IgG crosses the placenta. Diagnosis relies on PCR of saliva or urine collected within the first three weeks of life. Our guide also covers the full panel of blood tests during pregnancy.
Kemajuan ilmiah terkini
Recent research explains why guidance is shifting. Here is what it shows, in plain terms.
Antiviral treatment cuts transmission meaningfully. A meta-analysis pooling individual data from several trials, covering more than 500 women infected around conception or in early pregnancy, found the virus reached the fetus roughly a third as often in treated women compared with untreated ones. What this means for you: a worrying serology result now opens onto a treatment option rather than watchful waiting alone.
Timing drives the benefit. An Israeli team rewrote its own protocol to begin treatment several weeks earlier and saw a marked drop in positive amniocentesis results compared with the untreated group of their original trial. What this means for you: the value of testing early is not administrative, it is clinical, because the window for effective treatment is short.
Universal first-trimester screening is workable. A cohort study, meaning a group followed over time, enrolled more than 3,000 pregnant women in Barcelona and reported high acceptance of testing. About one in five women turned out not to be immune, and the few recent infections found were managed without any confirmed fetal infection. What this means for you: screening mostly identifies who needs prevention advice, not who has a problem.
Serology has real blind spots. A Canadian case series described congenital CMV in babies whose mothers had negative IgM in the second trimester. What this means for you: a normal later result does not undo the value of early testing, and when ultrasound raises concern, amniotic fluid PCR is the test that settles it. A 2024 UK review reaches a similar conclusion and notes that screening policy still varies widely between countries.
When to talk to your clinician
- You are pregnant or planning a pregnancy and spend time around young children, the main source of transmission.
- You develop fever, fatigue, sore throat or swollen glands in early pregnancy.
- An ultrasound reports findings such as growth restriction, enlarged ventricles or bowel changes.
- Your CMV blood test shows positive IgM, low avidity, or a change between two samples.
- Your newborn fails the hearing screen, which is a recognized trigger for CMV testing in several states.
Prevention remains the strongest lever and costs nothing. Wash hands after diaper changes and wiping noses, avoid sharing utensils, cups and toothbrushes, skip kisses on the mouth with toddlers, and clean surfaces that meet a child’s saliva. A previous infection does not fully protect against reinfection, so these habits stay useful even for immune parents. For general context on interpreting any report, see normal blood test ranges and what they represent.
Glosarium
| Ketentuan | Definisi |
|---|---|
| CMV (cytomegalovirus) | A very common herpes-family virus. Most infections cause no symptoms and go unnoticed. |
| Serologi | A blood test that looks for antibodies rather than the germ itself, showing whether your immune system has met it. |
| IgM | The antibody made first during an infection. Its presence suggests recency but does not prove it. |
| IgG | The antibody made later and kept long term. It marks past contact with the virus. |
| Aviditas IgG | A measure of how tightly antibodies bind the virus. Low avidity suggests a recent infection, high avidity an older one. |
| Infeksi primer | A person’s first infection with a given germ, as opposed to reactivation or reinfection. |
| Serokonversi | A shift from a negative to a positive antibody result between two blood draws. |
| Congenital CMV | Infection present in a baby at birth because the virus crossed the placenta during pregnancy. |
| PCR | A laboratory method that detects the genetic material of a virus, confirming its actual presence in a sample. |
| Amniocentesis | Sampling of a small amount of amniotic fluid, here used to look for the virus around the fetus. |
Pertanyaan yang sering diajukan
Is a positive CMV IgG result bad news?
Generally no. A positive IgG with a negative IgM means you were infected at some point in the past and your immune system has responded. In pregnancy this pattern is usually reassuring, because the highest risk to a baby comes from a first infection during early pregnancy. Immunity is not absolute, however, so hygiene precautions still make sense.
Does the United States screen all pregnant women for CMV?
No. Universal prenatal CMV screening is not standard practice in the US. Testing is targeted at women with symptoms, a known exposure, suggestive ultrasound findings, or immune suppression. Newborn screening is expanding at the state level, with some states testing every baby and others testing those who fail the hearing screen.
What is the difference between a CMV blood test and a CMV PCR?
A CMV blood test measures antibodies, which is your body’s record of having met the virus. A PCR looks for the virus itself in a sample such as amniotic fluid, saliva or urine. Antibodies answer whether and roughly when you were infected; PCR answers whether the virus is present right now in that specific sample.
Do I need to fast before a CMV blood test?
No. CMV serology is a standard blood draw with no fasting required and no special preparation. Results are usually available within a few days. Avidity testing may take longer, since fewer laboratories run it and samples are sometimes sent to a reference lab.
Can a CMV infection be treated during pregnancy?
There is no cure, but antiviral treatment with valacyclovir started early after a first-trimester infection can reduce the chance that the virus reaches the fetus. This use is off-label in the United States and is generally handled by maternal-fetal medicine specialists, so the decision is individual and made after a detailed discussion of benefits and side effects.
My baby has congenital CMV but seems fine. What now?
Most infected newborns have no visible signs at birth, yet some develop hearing loss later. That is why structured follow-up of hearing and development is recommended through at least the first years of life. When a baby has symptoms at birth, antiviral treatment can improve hearing and developmental outcomes for a substantial share of them.
Sumber
- Centers for Disease Control and Prevention — Laboratory Testing for CMV and Congenital CMV, 2024 — read the CDC guidance
- MedlinePlus, US National Library of Medicine, National Institutes of Health — Cytomegalovirus (CMV) Tests, 2024 — read the MedlinePlus page
- Mayo Clinic — Cytomegalovirus (CMV) infection: diagnosis and treatment, 2025 — read the Mayo Clinic page
- Chatzakis C. et al. — The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy: an individual patient data meta-analysis — American Journal of Obstetrics and Gynecology, 2023 — read the study
- Amir J. et al. — Revised protocol for secondary prevention of congenital cytomegalovirus infection with valaciclovir following infection in early pregnancy — Clinical Infectious Diseases, 2023 — read the study
- Sánchez-Durán M. Á. et al. — Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona (CITEMB Study) — BJOG, 2026 — read the study
- Chan E. S. et al. — Maternal Cytomegalovirus (CMV) Serology: The Diagnostic Limitations of CMV IgM and IgG Avidity in Detecting Congenital CMV Infection — Pediatric and Developmental Pathology, 2024 — read the study
- Khalil A. et al. — Congenital Cytomegalovirus Infection: Update on Screening, Diagnosis and Treatment (Scientific Impact Paper No. 56) — BJOG, 2024 — read the review
- Haute Autorité de Santé — First-trimester cytomegalovirus screening in pregnancy: management and follow-up, August 4, 2026 — read the French guideline
Bacaan lebih lanjut
- Cara Membaca Hasil Tes Darah Anda: Panduan Lengkap
- Hitung Sel Darah Lengkap (CBC): Cara Membaca Hasil Anda
- Hasil Tes Darah Abnormal: Apa Artinya dan Apa yang Harus Dilakukan
- Berapa Lama Hasil Tes Darah Keluar? Garis Waktu Berdasarkan Jenis Tes
- Apa yang Dapat Anda Harapkan Selama Tes Darah: Proses Lengkapnya
Pahami hasil lab Anda dengan AI DiagMe.
A CMV blood test rarely arrives alone. It usually sits inside a wider prenatal panel next to a blood count, a blood type and antibody screen, a glucose test and other serologies, and the meaning comes from reading those lines together. AI DiagMe translates that report into plain language so you walk into your appointment already understanding what was measured and why. It helps you understand your results, it does not diagnose, and it does not replace your doctor or midwife.
Dapatkan interpretasi hasil Anda dalam hitungan menit.
